Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 163 articles: HTML format Text format

Single Articles

January 2012
1. HARBECK N , Rody A
   Lost in Translation? Estrogen Receptor Status and Endocrine Responsiveness in Breast Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. DUBSKY PC , Jakesz R, Mlineritsch B, Postlberger S, et al
   Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BURSTEIN HJ , Griggs JJ
   Deep Time: The Long and the Short of Adjuvant Endocrine Therapy for Breast Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
4. YI M , Meric-Bernstam F, Kuerer HM, Mittendorf EA, et al
   Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MUNSTER PN , Moore AP, Ismail-Khan R, Cox CE, et al
   Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. DE GIORGI U , Amadori D
   Dose Intensification in Hormone Receptor-Negative and/or Human Epidermal Growth Factor Receptor 2-Negative High-Risk Primary Breast Cancer.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
7. NILSSON G , Holmberg L, Garmo H, Duvernoy O, et al
   Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. MORONI M
   High-Dose Chemotherapy As Adjuvant Therapy in Breast Cancer: Could There Be a Survival Benefit?
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. GAYKEMA SB , Brouwers AH, Hovenga S, Lub-de Hooge MN, et al
   Zirconium-89-Trastuzumab Positron Emission Tomography As a Tool to Solve a Clinical Dilemma in a Patient With Breast Cancer.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
10. ZAGAR TM , Marks LB
    Breast Cancer Radiotherapy and Coronary Artery Stenosis: Location, Location, Location.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. MAYER EL , Gropper AB, Neville BA, Partridge AH, et al
    Breast Cancer Survivors' Perceptions of Survivorship Care Options.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MACIS D , Gandini S, Guerrieri-Gonzaga A, Johansson H, et al
    Prognostic Effect of Circulating Adiponectin in a Randomized 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women at Risk for Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GOODWIN PJ , Ennis M, Pritchard KI, Trudeau ME, et al
    Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. CHLEBOWSKI RT
    Obesity and Breast Cancer Outcome: Adding to the Evidence.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
15. GOODWIN PJ , Phillips KA, West DW, Ennis M, et al
    Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. NAROD SA
    Should All Women With Breast Cancer Be Tested for BRCA Mutations at the Time of Diagnosis?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
17. GRIGGS JJ
    Role of Nonclinical Factors in the Receipt of High-Quality Systemic Adjuvant Breast Cancer Treatment.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
18. BRAUCH HB , Schroth W, Ingle JN, Goetz MP, et al
    CYP2D6 and tamoxifen: awaiting the denouement.
    J Clin Oncol. 2011;29:4589-90.
    PubMed     Text format     Related articles   
    
    
    
    
19. ROBSON M
    Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation?
    J Clin Oncol. 2011;29:4477-8.
    PubMed     Text format     Related articles   
    
    
    
    
20. HAFFTY BG , Hunt KK, Harris JR, Buchholz TA, et al
    Positive sentinel nodes without axillary dissection: implications for the radiation oncologist.
    J Clin Oncol. 2011;29:4479-81.
    PubMed     Text format     Related articles   
    
    
    
    
21. GONZALEZ-ANGULO AM , Hortobagyi GN
    Is there an ideal way to combine trastuzumab with chemotherapy?
    J Clin Oncol. 2011;29:4474-6.
    PubMed     Text format     Related articles   
    
    
    
    
22. BASILE FG , Creamer S
    Docetaxel/Cyclophosphamide-induced ultraviolet recall dermatitis.
    J Clin Oncol. 2011;29:e840-1.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
23. AMIR E , Miller N, Geddie W, Freedman O, et al
    Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. JOENSUU H , Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, et al
    Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. EARL HM
    Reporting of Adjuvant Breast Cancer Trials: When Is the Right Time?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. NICHOL AM , Yerushalmi R, Tyldesley S, Lesperance M, et al
    A Case-Match Study Comparing Unilateral With Synchronous Bilateral Breast Cancer Outcomes.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. 
    Retraction. Lymphocyte infiltration in breast cancer: a key prognostic factor that should not be ignored.
    J Clin Oncol. 2011;29:4471.
    PubMed     Text format     Related articles   
    
    
    
    
28. NIELSEN DL , Bjerre KD, Jakobsen EH, Cold S, et al
    Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. DEES EC
    Taxane Doublets for Metastatic Breast Cancer: Do We Need Another Cytotoxic Pair or Another Approach?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
30. YI M , Mittendorf EA, Cormier JN, Buchholz TA, et al
    Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current American Joint Committee on Cancer Staging System.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. HALBERT CH , Stopfer JE, McDonald J, Weathers B, et al
    Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?
    J Clin Oncol. 2011;29:4302-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. BARTLETT JM , Starczynski J
    Quantitative reverse transcriptase polymerase chain reaction and the Oncotype DX test for assessment of human epidermal growth factor receptor 2 status: time to reflect again?
    J Clin Oncol. 2011;29:4219-21.
    PubMed     Text format     Related articles   
    
    
    
    
33. RING A , Sestak I, Baum M, Howell A, et al
    Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial.
    J Clin Oncol. 2011;29:4266-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. HURRIA A
    Embracing the complexity of comorbidity.
    J Clin Oncol. 2011;29:4217-8.
    PubMed     Text format     Related articles   
    
    
    
    
35. DABBS DJ , Klein ME, Mohsin SK, Tubbs RR, et al
    High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study.
    J Clin Oncol. 2011;29:4279-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SMITH BD , Jiang J, McLaughlin SS, Hurria A, et al
    Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MUSS HB , Busby-Whitehead J
    Older Women With Breast Cancer: Slow Progress, Great Opportunity, Now Is the Time.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
38. TSE CH , Hwang HC, Goldstein LC, Kandalaft PL, et al
    Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.
    J Clin Oncol. 2011;29:4168-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. VALERO MG , Raut CP, Lotfi P, Golshan M, et al
    Atypical lipomatous tumor of the breast.
    J Clin Oncol. 2011;29:e766-8.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
40. GRUNFELD E , Julian JA, Pond G, Maunsell E, et al
    Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. PEREZ EA , Suman VJ, Davidson NE, Gralow JR, et al
    Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KURIAN AW , Gong GD, John EM, Johnston DA, et al
    Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. TRAINER AH , James PA, Mann GB, Lindeman GJ, et al
    Breast Conservation Versus Mastectomy in Triple-Negative Breast Cancer: Two Steps Forward, One Step Back?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
44. TSOUTSOU PG , Sozzi WJ, Matzinger O, Ozsahin M, et al
    Personalizing Locoregional Treatment in the Adjuvant Setting of Early Breast Cancer on the Basis of Molecular Background: An Exciting Enigma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
45. ROBIER C , Neubauer M, Beham-Schmid C, Sill H, et al
    Thrombotic Microangiopathy and Disseminated Intravascular Coagulation Associated With Carcinocythemia in a Patient With Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
46. DIGNAM JJ
    Some Additional Thoughts on Time-Varying Treatment Effects in Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
47. OZRETIC L , Rhiem K, Huss S, Wappenschmidt B, et al
    High Nuclear Poly(Adenosine Diphosphate-Ribose) Polymerase Expression Is Predictive for BRCA1- and BRCA2-Deficient Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
48. STOCKLER MR , Harvey VJ, Francis PA, Byrne MJ, et al
    Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. MILLER TW , Balko JM, Arteaga CL
    Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. PUSZTAI L
    Anatomy and Biology: Two Complementary Sides of Breast Cancer Prognostication.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
51. TANG G , Cuzick J, Costantino JP, Dowsett M, et al
    Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor-Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. LEE E , McKean-Cowdin R, Ma H, Spicer DV, et al
    Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. CUZICK J , Dowsett M, Pineda S, Wale C, et al
    Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. BRUFSKY AM , Hurvitz S, Perez E, Swamy R, et al
    RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Brea
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. MIAO H , Verkooijen HM, Chia KS, Bouchardy C, et al
    Incidence and Outcome of Male Breast Cancer: An International Population-Based Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
56. KIM C , Tang G, Pogue-Geile KL, Costantino JP, et al
    Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor-Positive Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. DOMCHEK SM , Mitchell G, Lindeman GJ, Tung NM, et al
    Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
58. LAUZIER S , Levesque P, Drolet M, Coyle D, et al
    Out-of-Pocket Costs for Accessing Adjuvant Radiotherapy Among Canadian Women With Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. DICKLER MN
    Targeting the Insulin-Like Growth Factor Pathway in Estrogen Receptor-Positive Breast Cancer: A Bumpy Start With an Uncertain Future.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
60. EIERMANN W , Pienkowski T, Crown J, Sadeghi S, et al
    Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2-Normal, Node-Positive Breast Cancer: BCIRG-005 Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. PRITCHARD KI , Shepherd LE, Chapman JA, Norris BD, et al
    Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. BOEKHOUT AH , Vincent AD, Dalesio OB, van den Bosch J, et al
    Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. COLZANI E , Liljegren A, Johansson AL, Adolfsson J, et al
    Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. BUCK K , Vrieling A, Zaineddin AK, Becker S, et al
    Serum Enterolactone and Prognosis of Postmenopausal Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. ARVOLD ND , Taghian AG, Niemierko A, Abi Raad RF, et al
    Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. GRIGGS JJ , Somerfield MR, Anderson H, Henry NL, et al
    American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early-Stage Invasive Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. ROBSON ME
    Should the Presence of Germline BRCA1/2 Mutations Influence Treatment Selection in Breast Cancer?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
68. PATTERSON RE
    Flaxseed and Breast Cancer: What Should We Tell Our Patients?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
69. ARUN B , Bayraktar S, Liu DD, Gutierrez Barrera AM, et al
    Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. WRIGHT JD , Neugut AI, Wilde ET, Buono DL, et al
    Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer.
    J Clin Oncol. 2011;29:3408-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. CAMERON DA
    Chemotherapy, trastuzumab, and pathological complete response: when shall we three meet again?
    J Clin Oncol. 2011;29:3344-6.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
72. CYBULSKI C , Wokolorczyk D, Jakubowska A, Huzarski T, et al
    Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. TUNG N , Silver DP
    Chek2 DNA Damage Response Pathway and Inherited Breast Cancer Risk.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
74. KORDE LA , Gralow JR
    Can We Predict Who's at Risk for Developing Bone Metastases in Breast Cancer?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
75. LIPTON A , Chapman JA, Demers L, Shepherd LE, et al
    Elevated Bone Turnover Predicts for Bone Metastasis in Postmenopausal Breast Cancer: Results of NCIC CTG MA.14.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. IRVIN WJ JR , Walko CM, Weck KE, Ibrahim JG, et al
    Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.
    J Clin Oncol. 2011;29:3232-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. BLUMENFELD Z
    ZORO study: discrepancy between the conclusion and the results.
    J Clin Oncol. 2011;29:3340.
    PubMed     Text format     Related articles   
    
    
    
    
78. RAE JM
    Personalized tamoxifen: what is the best way forward?
    J Clin Oncol. 2011;29:3206-8.
    PubMed     Text format     Related articles   
    
    
    
    
79. DE GRAAN AJ , Teunissen SF, de Vos FY, Loos WJ, et al
    Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment.
    J Clin Oncol. 2011;29:3240-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. GRALOW JR , Lipton A, Stopeck AT
    How Do We Define Efficacy in Comparing Osteoclast-Targeted Agents in Metastatic Breast Cancer?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
81. BOWER JE , Ganz PA, Irwin MR, Kwan L, et al
    Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. BARTLETT JM , Rea D, Rimm DL
    Quantification of Hormone Receptors to Guide Adjuvant Therapy Choice in Early Breast Cancer: Better Methods Required for Improved Utility.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
83. WOLFF AC , Dowsett M
    Estrogen receptor: a never ending story?
    J Clin Oncol. 2011;29:2955-8.
    PubMed     Text format     Related articles   
    
    
    
    
84. NAROD SA , Iqbal J
    Tamoxifen chemoprevention and cardiac disease.
    J Clin Oncol. 2011;29:3106-7.
    PubMed     Text format     Related articles   
    
    
    
    
85. LORUSSO PM , Boerner SA, Hunsberger S
    Clinical development of vascular disrupting agents: what lessons can we learn from ASA404?
    J Clin Oncol. 2011;29:2952-5.
    PubMed     Text format     Related articles   
    
    
    
    
86. DE SIMONE N , Aggon A, Christy C
    Granular cell tumor of the breast: clinical and pathologic characteristics of a rare case in a 14-year-old girl.
    J Clin Oncol. 2011;29:e656-7.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
87. LU Y , Ma H, Malone KE, Norman SA, et al
    Obesity and Survival Among Black Women and White Women 35 to 64 Years of Age at Diagnosis With Invasive Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. UNTCH M , Fasching PA, Konecny GE, Hasmuller S, et al
    Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. ARVOLD ND , Hsu L, Chen WY, Benzaquen LR, et al
    Marantic Endocarditis With Cardioembolic Strokes Mimicking Leptomeningeal Metastases in Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
90. BERRY DA , Ueno NT, Johnson MM, Lei X, et al
    High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. DEL MASTRO L
    Temporary Ovarian Suppression With Goserelin and Ovarian Function Protection in Patients With Breast Cancer Undergoing Chemotherapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
92. MCCOWAN C , Dewar JA, Thompson AM
    Importance of Long-Term Follow-Up of Women Receiving Adjuvant Therapy for Breast Cancer in the Community.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
93. PEREZ EA , Romond EH, Suman VJ, Jeong JH, et al
    Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. BORGES VF , Elias AD
    The Era of High-Dose Chemotherapy for Breast Cancer: Revisiting a Troubled Quest.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
95. BERRY DA , Ueno NT, Johnson MM, Lei X, et al
    High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. COOMBES RC , Bliss JM, Espie M, Erdkamp F, et al
    Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. KHANH MORROW P , Wulf GM, Ensor J, Booser DJ, et al
    Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. CHANDARLAPATY S , Modi S
    Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Can There Be Too Many Active Drugs?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
99. BOYD NF , Melnichouk O, Martin LJ, Hislop G, et al
    Mammographic Density, Response to Hormones, and Breast Cancer Risk.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. WELSH AW , Moeder CB, Kumar S, Gershkovich P, et al
     Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather Than Percentage of Positive Cells.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. ZENDEJAS B , Moriarty JP, O'Byrne J, Degnim AC, et al
     Cost-Effectiveness of Contralateral Prophylactic Mastectomy Versus Routine Surveillance in Patients With Unilateral Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. HAWKES EA , Okines AF, Plummer C, Cunningham D, et al
     Cardiotoxicity in patients treated with bevacizumab is potentially reversible.
     J Clin Oncol. 2011;29:e560-2.
     PubMed     Text format     Related articles   
     
     
     
     
103. TWEARDY D , Chang JC
     Stat5: from breast development to cancer prognosis, prediction, and progression.
     J Clin Oncol. 2011;29:2443-4.
     PubMed     Text format     Related articles   
     
     
     
     
104. DOWSETT M , Smith IE
     Presurgical Progesterone in Early Breast Cancer: So Much for So Little?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
105. BADWE R , Hawaldar R, Parmar V, Nadkarni M, et al
     Single-Injection Depot Progesterone Before Surgery and Survival in Women With Operable Breast Cancer: A Randomized Controlled Trial.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. RUSSILLO M , Di Benedetto A, Metro G, Ferretti G, et al
     Assessment of PTEN and PI3K Status in Primary Breast Cancer and Corresponding Metastases: Is It Worthwhile?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
107. ABDULKARIM BS , Cuartero J, Hanson J, Deschenes J, et al
     Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. KORN EL , Freidlin B, Abrams JS
     Overall survival as the outcome for randomized clinical trials with effective subsequent therapies.
     J Clin Oncol. 2011;29:2439-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. TAUNK NK , Haffty BG, Goyal S
     Radiation Recall 5 Years After Whole-Breast Irradiation for Early-Stage Breast Cancer Secondary to Initiation of Rosuvastatin and Amlodipine.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     May 2011
110. BARRON TI , Connolly RM, Sharp L, Bennett K, et al
     Beta Blockers and Breast Cancer Mortality: A Population-Based Study.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. MELHEM-BERTRANDT A , Chavez-Macgregor M, Lei X, Brown EN, et al
     Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. GANZ PA , Cole SW
     Expanding Our Therapeutic Options: Beta Blockers for Breast Cancer?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
113. HERNANDEZ-AYA LF , Chavez-Macgregor M, Lei X, Meric-Bernstam F, et al
     Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. NEUGUT AI , Subar M, Wilde ET, Stratton S, et al
     Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. WO JY , Chen K, Neville BA, Lin NU, et al
     Effect of Very Small Tumor Size on Cancer-Specific Mortality in Node-Positive Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. COMEN EA , Norton L, Massague J
     Breast Cancer Tumor Size, Nodal Status, and Prognosis: Biology Trumps Anatomy.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
117. ELKIN EB , Klem ML, Gonzales AM, Ishill NM, et al
     Characteristics and Outcomes of Breast Cancer in Women With and Without a History of Radiation for Hodgkin's Lymphoma: A Multi-Institutional, Matched Cohort Study.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. PECK AR , Witkiewicz AK, Liu C, Stringer GA, et al
     Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. SCHNEIDER BP , Sledge GW Jr
     Anti-Vascular Endothelial Growth Factor Therapy for Breast Cancer: Can We Pick the Winners?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
120. JATOI I , Anderson WF, Jeong JH, Redmond CK, et al
     Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
121. ELLIS MJ , Suman VJ, Hoog J, Lin L, et al
     Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. RUGO HS , Stopeck AT, Joy AA, Chan S, et al
     Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. PFEILER G , Konigsberg R, Fesl C, Mlineritsch B, et al
     Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. AMIR E , Goodwin PJ
     Breast Cancer Chemoprevention Gets Personal.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
125. O'FLYNN EA , Wilson R, Nerurkar A, Johnston SR, et al
     Metastatic Breast Cancer in a Young Adult Man After Total-Body Irradiation for Acute Lymphoblastic Leukemia.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
126. GERBER B , von Minckwitz G, Stehle H, Reimer T, et al
     Effect of Luteinizing Hormone-Releasing Hormone Agonist on Ovarian Function After Modern Adjuvant Breast Cancer Chemotherapy: The GBG 37 ZORO Study.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
127. FREEDMAN AN , Yu B, Gail MH, Costantino JP, et al
     Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
128. BURNESS ML , Olopade OI
     Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?
     J Clin Oncol. 2011;29:1652-4.
     PubMed     Text format     Related articles   
     
     
     
     April 2011
129. VON MINCKWITZ G , Muller BM, Loibl S, Budczies J, et al
     Cytoplasmic Poly(Adenosine Diphosphate-Ribose) Polymerase Expression Is Predictive and Prognostic in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
130. DENT RA , Bristow RG
     In Situ DNA Repair Assays As Guides to Personalized Breast Cancer Chemotherapeutics: Ready for Prime Time?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
131. HAMMOND ME , Hayes DF, Wolff AC
     Clinical Notice for American Society of Clinical Oncology-College of American Pathologists Guideline Recommendations on ER/PgR and HER2 Testing in Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
132. MAHMOUD SM , Paish EC, Powe DG, Macmillan RD, et al
     Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. MOUAWAD R , Spano JP, Khayat D
     Lymphocyte Infiltration in Breast Cancer: A Key Prognostic Factor That Should Not Be Ignored.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
134. MOULDER S , Moroney J, Helgason T, Wheler J, et al
     Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
135. MITTENDORF EA , Jeruss JS, Tucker SL, Kolli A, et al
     Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. AAPRO MS
     Denosumab for Bone Metastases From Breast Cancer: A New Therapy Option?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
137. GENNARI A , Stockler M, Puntoni M, Sormani M, et al
     Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
138. WARNER E , Hill K, Causer P, Plewes D, et al
     Prospective Study of Breast Cancer Incidence in Women With a BRCA1 or BRCA2 Mutation Under Surveillance With and Without Magnetic Resonance Imaging.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. PEATE M , Meiser B, Friedlander M, Zorbas H, et al
     It's Now or Never: Fertility-Related Knowledge, Decision-Making Preferences, and Treatment Intentions in Young Women With Breast Cancer--An Australian Fertility Decision Aid Collaborative Group Study.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. PRITCHARD KI , Sousa B
     Long-Term Follow-Up of Women in Trials of Adjuvant Therapy for Breast Cancer: Is It Still Important?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
141. MACKEY JR
     Can Quantifying Hormone Receptor Levels Guide the Choice of Adjuvant Endocrine Therapy for Breast Cancer?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
142. BIGGAR RJ , Wohlfahrt J, Oudin A, Hjuler T, et al
     Digoxin Use and the Risk of Breast Cancer in Women.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. HACKSHAW A , Roughton M, Forsyth S, Monson K, et al
     Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. COLLEONI M , Giobbie-Hurder A, Regan MM, Thurlimann B, et al
     Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
     J Clin Oncol. 2011;29:1117-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. FINKELSTEIN DM , Schoenfeld DA
     Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method.
     J Clin Oncol. 2011;29:1093-5.
     PubMed     Text format     Related articles   
     
     
     
     
146. NICHOLS HB , Berrington de Gonzalez A, Lacey JV Jr, Rosenberg PS, et al
     Declining Incidence of Contralateral Breast Cancer in the United States From 1975 to 2006.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. SCHONBERG MA , Marcantonio ER, Ngo L, Li D, et al
     Causes of Death and Relative Survival of Older Women After a Breast Cancer Diagnosis.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. BURSTEIN HJ
     Bevacizumab for Advanced Breast Cancer: All Tied Up With a RIBBON?
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
149. ROBERT NJ , Dieras V, Glaspy J, Brufsky AM, et al
     RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
150. VAN POZNAK CH , Temin S, Yee GC, Janjan NA, et al
     American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. GANZ PA , Kwan L, Stanton AL, Bower JE, et al
     Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. GANZ PA , Land SR, Geyer CE Jr, Cecchini RS, et al
     Menstrual History and Quality-of-Life Outcomes in Women With Node-Positive Breast Cancer Treated With Adjuvant Therapy on the NSABP B-30 Trial.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. KIELY BE , Wilcken NR, Stockler MR
     Life After Adjuvant Chemotherapy for Breast Cancer: The News Is Mostly Good.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
154. KORNBLITH AB , Lan L, Archer L, Partridge A, et al
     Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. SCHAPIRA L
     Simple rules can improve prognostic accuracy.
     J Clin Oncol. 2011;29:347-9.
     PubMed     Text format     Related articles   
     
     
     
     January 2011
156. SPRAGGS CF , Budde LR, Briley LP, Bing N, et al
     HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. PEREZ EA , Jenkins RB, Dueck AC, Wiktor AE, et al
     C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. ELLIS GK , Barlow WE, Gralow JR, Hortobagyi GN, et al
     Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 001
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. LOO CE , Straver ME, Rodenhuis S, Muller SH, et al
     Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. MAZOUNI C , Delaloge S, Rimareix F, Garbay JR, et al
     Nomogram for risk of relapse after breast-conserving surgery in ductal carcinoma in situ.
     J Clin Oncol. 2011;29:e44.
     PubMed     Text format     Related articles   
     
     
     
     
161. DAVE B , Migliaccio I, Gutierrez MC, Wu MF, et al
     Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers.
     J Clin Oncol. 2011;29:166-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
162. RIJNSBURGER AJ , Obdeijn IM, Kaas R, Tilanus-Linthorst MM, et al
     BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
     J Clin Oncol. 2010;28:5265-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
163. KUNITAKE H , Zheng P, Yothers G, Land SR, et al
     Routine Preventive Care and Cancer Surveillance in Long-Term Survivors of Colorectal Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: